Forkhead box transcription factor 1: role in the pathogenesis of diabetic cardiomyopathy

Area of Science:

• Cardiology and Endocrinology
• Molecular Biology and Genetics

Background:

• Diabetic cardiomyopathy (DCM) is a distinct heart muscle disorder in diabetic patients, separate from hypertension or vascular issues.
• The precise molecular mechanisms driving DCM pathogenesis remain largely unclear.
• Transcription factors are implicated in the cardiac injury associated with diabetes.

Purpose of the Study:

• To review the role of the Forkhead box transcription factor 1 (FOXO1) pathway in diabetic cardiomyopathy.
• To elucidate how FOXO1 influences key processes implicated in DCM, including metabolism, oxidative stress, endothelial dysfunction, inflammation, and apoptosis.

Main Methods:

• Literature review focusing on studies investigating FOXO1.
• Analysis of research linking FOXO1 expression and function to cardiovascular diseases, particularly DCM.
• Synthesis of findings related to FOXO1's involvement in metabolic, oxidative, inflammatory, and apoptotic pathways relevant to DCM.

Main Results:

• Altered FOXO1 expression and function are associated with various cardiovascular diseases.
• FOXO1 plays a significant role in regulating cellular metabolism, oxidative stress responses, endothelial function, inflammation, and apoptosis.
• Emerging evidence highlights FOXO1's critical involvement in the development and progression of DCM.

Conclusions:

• The FOXO1 pathway is a key regulator in processes underlying diabetic cardiomyopathy.
• Targeting FOXO1 may offer a novel therapeutic strategy for managing DCM.
• Further research into FOXO1's intricate role is crucial for understanding and treating diabetic heart disease.